EQIX
59
2
EOG
28
2
MHK
25
5
FE
34
4
SCHW
40
3
CHRW
53
2
BAC
38
3
CNP
59
17
XRX
48
2
O
26
16
BXP
39
5
VFC
56
6
JWN
72
9
MA
60
5
EXR
42
5
AFL
34
6
SYK
50
4
RL
73
5
MDLZ
28
2
HOG
29
4
EQIX
59
2
EOG
28
2
MHK
25
5
FE
34
4
SCHW
40
3
CHRW
53
2
BAC
38
3
CNP
59
17
XRX
48
2
O
26
16
BXP
39
5
VFC
56
6
JWN
72
9
MA
60
5
EXR
42
5
AFL
34
6
SYK
50
4
RL
73
5
MDLZ
28
2
HOG
29
4
Financhill
Back

Palisade Bio 10K Form

Sell
27

PALI
Palisade Bio

Last Price:
$1.76
Seasonality Move:
3.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PALI News And Ratings

See the #1 stock for the next 7 days that we like better than PALI

PALI Financial Statistics

Sales & Book Value

Annual Sales: $250K
Cash Flow: $-3.1M
Price / Cash Flow: 0
Annual Sales: $4.72
Price / Book: 0.41

Profitability

EPS (TTM): -13.99000
Net Income (TTM): $-14.1M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Palisade Bio Earnings Forecast

Key Palisade Bio Financial Ratios

  • The Research & Development expenses have been 2,757.20% of Revenue.
  • The Interest Expense is -0.12% of Operating Income.
  • The Net Earning history of PALI is -4,920.00% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 3 years.

Palisade Bio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PALI
Website: palisadebio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PALI Technical Analysis vs Fundamental Analysis

Sell
27
Palisade Bio (PALI) is a Sell

Is Palisade Bio a Buy or a Sell?

  • Palisade Bio stock is rated a Sell
    The current Palisade Bio [PALI] share price is $1.75. The Score for PALI is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.